Cardio Diagnostics (CDIO) Announces 1:30 Reverse Share Split
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Cardio Diagnostics Holdings, Inc. Announces 1-for-30 Reverse Stock Split
May 8, 2025 8:35 AM EDTCHICAGO--(BUSINESS WIRE)-- Cardio Diagnostics Holdings, Inc. (Cardio or the Company) (NASDAQ: CDIO), today announced a 1-for-30 reverse stock split of its common stock effective with the market opening on May 13, 2025.
The reverse stock split will take effect at 11:59 pm Eastern Time on May 12, 2025, and the Companys common stock will open for trading on The Nasdaq Capital Market on May 13, 2025 on a post-split basis, under the existing ticker symbol CDIO but with new CUSIP number 14159C202. The reverse stock split is part of the Companys plan to regain compliance with the minimum bid... More



